Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display session

253P - Prognostic nutritional index is an independent risk factor for continuing S-1 adjuvant chemotherapy in patients with pancreatic cancer who received neoadjuvant chemotherapy and surgical resection

Date

07 Dec 2024

Session

Poster Display session

Presenters

Shinnosuke Kawahara

Citation

Annals of Oncology (2024) 35 (suppl_4): S1450-S1504. 10.1016/annonc/annonc1688

Authors

S. Kawahara1, T. Aoyama2, M. Murakawa1, R. Kanemoto1, N. Matsushita1, I. Hashimoto2, Y. Maezawa2, M. Kamiya3, S. Kobayashi4, M. Ueno5, N. Yamamoto1, T. Oshima3, N. Yukawa2, A. Saito2, S. Morinaga3

Author affiliations

  • 1 Department Of Gastrointestinal Surgery, Kanagawa Cancer Center, 241-8515 - Yokohama/JP
  • 2 Department Of Surgery, Yokohama City University Hospital, 236-004 - Yokohama/JP
  • 3 Department Of Gastrointestinal Surgery, Kanagawa Cancer Center, 2410815 - Yokohama/JP
  • 4 Department Of Gastroenterology, Kanagawa Cancer Center, 241-8515 - Yokohama/JP
  • 5 Department Of Gastroenterology, Kanagawa Cancer Center, 2410815 - Yokohama/JP

Resources

This content is available to ESMO members and event participants.

Abstract 253P

Background

Reports on the association of perioperative nutritional and inflammatory status with the clinical course of adjuvant chemotherapy did not include neoadjuvant chemotherapy. We aimed to clarify the mechanism by which perioperative nutritional and inflammatory status affect the clinical course of postoperative adjuvant chemotherapy in patients with pancreatic cancer.

Methods

We enrolled 123 patients with pancreatic cancer retrospectively who underwent surgical resection with neoadjuvant and S-1 adjuvant chemotherapy betweenJanuary 2013 and December 2022. The duration of continuing S-1 treatment and the continuation rates at 3 and 6 months after initiating adjuvant chemotherapy were calculated using the Kaplan–Meier method. The log-rank test was used to evaluate statistical differences between the high and low prognostic nutritional index (PNI) groups. Univariate and multivariate analyses were performed to determine the risk factors for continuing S-1 adjuvant chemotherapy.

Results

The optimal cut-off value for preoperative PNI was 45. Preoperative PNI was an independent risk factor for continuing S-1 adjuvant chemotherapy in patients who underwent perioperative adjuvant chemotherapy and surgical resection (hazard ratio =2.435, 95% confidence interval= 1.229−4.824, p=0.011). Low PNI was associated with lower S-1completion (p=0.02) and higher S-1 withdrawal (p=0.031). Additionally, the preoperative PNI status affected ≥grade 2 adverse events caused by adjuvant chemotherapy (p<0.001).

Conclusions

Preoperative PNI affected adjuvant chemotherapy continuation and related adverse events in patients who underwent neoadjuvant chemotherapy and curative resection. Additional perioperative anti-inflammatory management and nutritional support may be required to improve the clinical course of postoperative adjuvant chemotherapy and patient survival.

Clinical trial identification

All protocols were approved by the Ethics Committee of Kanagawa Cancer Center (approval number: 2023 epidemiologic study-169).

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.